Match!

A Mendelian Randomization Analysis Of Lipoprotein(A) Lowering And Cardiovascular Risk Stratified By Ldl Cholesterol, Gender, And Antiplatelet Therapy: Implications For Clinical Outcome Trials

Published on 2019in Atherosclerosis4.25
· DOI :10.1016/j.atherosclerosis.2019.06.021
J. L. Katzmann , Ulrich Laufs68
Estimated H-index: 68
,
B. A. Ference
  • References (0)
  • Citations (0)
References0
Newest
Cited By0
Newest
View next paperLPA variants, risk of coronary disease, and estimated clinical benefit of lipoprotein(a) lowering therapies: A mendelian randomization analysis